519 related articles for article (PubMed ID: 19575096)
1. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
2. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
3. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
4. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
5. The JUPITER trial: How will it change clinical practice?
Watson KE
Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
7. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
8. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
9. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
10. Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.
Cardiovasc J Afr; 2008; 19(2):117. PubMed ID: 18516361
[No Abstract] [Full Text] [Related]
11. Rosuvastatin in patients with elevated C-reactive protein.
Chan PS; Nallamothu BK; Hayward RA
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
[No Abstract] [Full Text] [Related]
12. Another look at the results of the JUPITER trial.
Kappagoda CT; Amsterdam EA
Am J Cardiol; 2009 Dec; 104(11):1603-5. PubMed ID: 19932800
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin in patients with elevated C-reactive protein.
Pierard LA
N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
[No Abstract] [Full Text] [Related]
14. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
Duvernoy CS; Blumenthal R
Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
[No Abstract] [Full Text] [Related]
15. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
16. [JUPITER study, more reason to give statins as preventive measure - commentary].
Narkiewicz K
Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
[No Abstract] [Full Text] [Related]
17. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
Håkansson J
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
[No Abstract] [Full Text] [Related]
18. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
[No Abstract] [Full Text] [Related]
19. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
Lubsen J
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
[No Abstract] [Full Text] [Related]
20. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
